Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deng-Fu Yao

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Zhonghua Yi Xue Za Zhi|January 8, 2011
[Dynamic alterations of VEGF and intervention of its expression on effect of hepatocyte malignant transformation]Deng-fu Yao, Li-wei Qiu, Wei Wu, et al.
World Journal of Gastroenterology|August 22, 2007
Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infectionIchiro Shimizu, Nao Kohno, Katsuyoshi Tamaki, et al.
World Journal of Gastroenterology|January 31, 2002
Expression and kinetic changes of alkaline phosphatase and its isoenzymes in experimental rat hepatomaMing-Bing Xiao, Deng-Fu Yao, Hong Zhang, et al.
World Journal of Clinical Oncology|November 3, 2025
Abnormal expression and potential clinical value of oncogenic Krüppel-like factor-5 in lung squamous cell carcinomaYang Shi, Wen-Li Sai, Jin-Liang Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 16, 2005
Abnormal expression of hepatomas and circulating telomerase and its clinical valuesWei Wu, Deng-Fu Yao, Li-Wei Qiu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 3, 2007
[An evaluation of transforming growth factor-beta 1 in diagnosing hepatocellular carcinoma and metastasis]Zhi-zhen Dong, Deng-fu Yao, Li Zou, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 12, 2008
Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma developmentLi-Wei Qiu, Deng-Fu Yao, Lei Zong, et al.
World Journal of Gastroenterology|April 15, 2016
Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinomaLiu-Hong Pan, Min Yao, Yin Cai, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 10, 2010
[Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells]Yi-lang Wang, Deng-fu Yao, Wei Wu, et al.
World Journal of Gastroenterology|February 5, 2026
Stemness CD24 activation promotes hepatocellular carcinoma progression <i>via</i> an immune escape mechanismYin Cai, Lu-Yin Liu, Xiao-Xiao Xia, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Zhonghua Yi Xue Za Zhi|January 8, 2011
[Dynamic alterations of VEGF and intervention of its expression on effect of hepatocyte malignant transformation]Deng-fu Yao, Li-wei Qiu, Wei Wu, et al.
World Journal of Gastroenterology|August 22, 2007
Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infectionIchiro Shimizu, Nao Kohno, Katsuyoshi Tamaki, et al.
World Journal of Gastroenterology|January 31, 2002
Expression and kinetic changes of alkaline phosphatase and its isoenzymes in experimental rat hepatomaMing-Bing Xiao, Deng-Fu Yao, Hong Zhang, et al.
World Journal of Clinical Oncology|November 3, 2025
Abnormal expression and potential clinical value of oncogenic Krüppel-like factor-5 in lung squamous cell carcinomaYang Shi, Wen-Li Sai, Jin-Liang Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 16, 2005
Abnormal expression of hepatomas and circulating telomerase and its clinical valuesWei Wu, Deng-Fu Yao, Li-Wei Qiu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 3, 2007
[An evaluation of transforming growth factor-beta 1 in diagnosing hepatocellular carcinoma and metastasis]Zhi-zhen Dong, Deng-fu Yao, Li Zou, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 12, 2008
Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma developmentLi-Wei Qiu, Deng-Fu Yao, Lei Zong, et al.
World Journal of Gastroenterology|April 15, 2016
Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinomaLiu-Hong Pan, Min Yao, Yin Cai, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 10, 2010
[Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells]Yi-lang Wang, Deng-fu Yao, Wei Wu, et al.
World Journal of Gastroenterology|February 5, 2026
Stemness CD24 activation promotes hepatocellular carcinoma progression <i>via</i> an immune escape mechanismYin Cai, Lu-Yin Liu, Xiao-Xiao Xia, et al.
Pageof 6